IMPORTANT NOTE: 2/2/22 Pathology Grand Rounds will be ONLINE ONLY
Anshu Bandhlish, MD Clinical Instructor, Anatomic Pathology Department of Laboratory Medicine & Pathology University of Washington Objectives: - Understand the evolution and updates in the classification of primary bone sarcomas.
- Approach to diagnosis of rare primary bone sarcomas based on morphology, immunohistochemistry and molecular characterization.
- Recent updates in treatment and management of primary bone sarcomas.
Speaker disclosures: Dr. Anshu Bandhlish has NOT had any financial relationships with any ineligible entities within the past 24 months. Why Attend? Sarcomas of bone are one of the most challenging areas of surgical pathology (0.2% of all malignant tumors). Primary soft tissue sarcoma presenting primarily in bone (comprising 5-10% of bone sarcomas) pose a far greater challenge owing to their extreme rarity and lack of awareness. Advent of an increased number of new immunohistochemical markers and recent advances in molecular analyses has led to a deeper knowledge and a more detailed understanding of these rare bone tumors. This talk will discuss the evolution of classification of these rare bone sarcomas (non-osteosarcoma, non-chondrosarcoma and non-Ewing sarcoma) with recent updates on their current classification. This objective of this talk is to create awareness about these rare bone sarcomas, discuss their clinical presentation, diverse radiological presentations, morphologic features, characteristic immunohistochemical and molecular findings and potential diagnostic pitfalls. There is a lot of uncertainty regarding the treatment of these primary bone sarcomas with no consensus on the systemic therapies, currently available for the more well-known sarcomas. This talk summarizes the medical scientific literature and current research in the treatment of these rare sarcomas. Meeting ID: 931 1873 4050
Passcode: PGR2122You must sign-in on the following form to receive CME credit. Sign-in online: https://forms.gle/W2oE8d3MYbnyTDe58
Planning Committee Disclosure: The following members have not had any financial relationships with any ineligible entities in the past 24 months: Drs. Rebecca Alvarez, Eleanor Chen, Lisa Koch, Jose Mantilla, Elizabeth Parker, Maria Tretiakova, Larry True, James Malleis, and Trent Irwin. The following members disclose financial relations with ineligible entities within the past 24 months: Dr Shreeram Akilesh discloses a financial relationship (speaker honorarium) with GoldfinchBio, Inc.; Dr. Haodong Xu discloses a financial relationship with PathomIQ (consultant). All relevant financial relationships listed have been mitigated.
Grant Acknowledgment: None
CME Accreditation statement: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Washington School of Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit) |